Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Biological Psychology|May 26, 2009
As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disordersLineke M Tak, Harriëtte Riese, Geertruida H de Bock, et al.Biological Psychology|February 15, 2011
Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disordersLineke M Tak, Anthony J Cleare, Johan Ormel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018
Molecular Imaging in Cancer Drug DevelopmentStijn J H Waaijer, Iris C Kok, Bertha Eisses, et al.Molecular Imaging and Biology|October 4, 2022
Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry CalculationsJoyce van Sluis, Walter Noordzij, Elisabeth G E de Vries, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Theranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L Moek, Danique Giesen, Iris C Kok, et al.Frontiers in Oncology|June 26, 2020
Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaSaskia H Hanemaaijer, Iris C Kok, Rudolf S N Fehrmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 ProbodyLaura Kist de Ruijter, Jahlisa S Hooiveld-Noeken, Danique Giesen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2019
<sup>89</sup>Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor UptakeKirsten L Moek, Stijn J H Waaijer, Iris C Kok, et al.Nature Medicine|November 28, 2018
<sup>89</sup>Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancerFrederike Bensch, Elly L van der Veen, Marjolijn N Lub-de Hooge, et al.Pageof 1